Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis

por Vallerskog, Therese, Heimbürger, Mikael, Gunnarsson, Iva, Zhou, Wei, Wahren-Herlenius, Marie, Trollmo, Christina, Malmström, Vivianne
Publicado 2006

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus

por Anania, Cristina, Gustafsson, Thomas, Hua, Xiang, Su, Jun, Vikström, Max, de Faire, Ulf, Heimbürger, Mikael, Jogestrand, Tomas, Frostegård, Johan
Publicado 2010

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinic...

por Chatzidionysiou, Katerina, Turesson, Carl, Teleman, Annika, Knight, Ann, Lindqvist, Elisabet, Larsson, Per, Cöster, Lars, Forslind, Kristina, van Vollenhoven, Ronald, Heimbürger, Mikael
Publicado 2016